Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ABBVIE INC.

(ABBV)
  Report
Delayed Nyse  -  04:03:15 2023-01-30 pm EST
145.65 USD   -0.43%
01/25Allergan Aesthetics takes a 360░approach to non-surgical aesthetic treatments to improve patient outcomes with expert-led medical education symposium at IMCAS 2023
PR
01/23Abbvie : St. Jude Children's Research Hospital unveils 45,000-square-foot Family Commons
PU
01/20Netflix changes management, T-Mobile US hacked again: MarketScreener's World Press Review, January 20
MS
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Sector news Other Pharmaceuticals
04:03pSector Update: Health Care Stocks' Losses Gain Speed Near Monday Close
MT
03:44pSector Update: Health Care
MT
02:30pJohnson & Johnson Worst Performer in the DJIA So Far Today -- Data Talk
DJ
02:11pTop Midday Decliners
MT
01:20pMega-Cap Tech Earnings on Tap; Fed's Policy Leanings Cool US Equity Investors' Risk App..
MT
01:02pDrugmakers prevail in dispute over U.S. discount drug program
RE
12:25pAstraZeneca Doses First Patient in Phase 3 Study of Datopotamab Deruxtecan to Treat Lun..
MT
12:03pJohnson & Johnson's Bankruptcy Petition for Talc Unit Dismissed by Court; Shares Down M..
MT
11:59aJohnson & Johnson Stock Falls Amid Reports US Appeals Court Rejected Company's Use of B..
MT
11:41aJohnson & Johnson Talc Bankruptcy Case Thrown Out b..
MT
11:36aDaiichi begins Tropion-Lung07 phase 3 trial for lung cancer treatment
AN
11:06aEuropean Equities Start the Week Modestly Higher Amid German GDP Contraction
MT
08:01aBerenberg Bank Adjusts Merck & Company Price Target to $125 From $115, Maintains Buy Ra..
MT
07:53aBerenberg Lowers Price Target on Roche, Maintains Buy Recommendation
MT
06:59aROCHE HOLDINGS AG : Berenberg reiterates its Buy rating
MD
01/27Eli Lilly's Oncology Unit Gets US FDA's Approval for Mantle Cell Lymphoma Drug
MT
01/27FDA Approves Eli Lilly's Jaypirca to Treat Lymphoma Patients
DJ
01/27Eli Lilly Receives US FDA's Nod of Jaypirca to Treat Mantle Cell Lymphoma
MT
01/27Eli Lilly and Company Announces That the U.S. Food and Drug Administration Approved Jay..
CI
01/27Johnson & Johnson's Janssen Says Carvykti Meets Target in Late-Stage Blood Cancer Trial
MT
01/27Eli Lilly's Diabetes Drug Recommended for Approval by European Medicines Agency Committ..
MT
01/27Johnson & Johnson Unit Withdraws European Application for Imbruvica Drug Combination to..
MT
01/27Merck Says Keytruda Approved by FDA as Adjuvant Treatment for Non-Small Cell Lung Cance..
MT
01/27Merck Announces the U.S. Food and Drug Administration has Approved KEYTRUDA
CI
01/26Merck & Co.'s Animal Health Unit Wins US FDA Nod for Expanded Use of Flea Drug for Dogs
MT
01/26Sector Update: Healthcare Stocks Climb Back to Finish Higher
MT
01/26Merck Animal Health Division Says US FDA Approves Expanded Indication of Bravecto Chews..
MT
01/26Eli Lilly Earmarks $1 Million to Boost Cold Chain Capacity in 17 Countries
MT
01/26Sector Update: Health Care Stocks Advance Pre-Bell Thursday
MT
01/26Evotec, Johnson & Johnson's Janssen Biotech Enter Cancer Drug Development Collaboration
MT
01/26Evotec Shares Climb After Agreement With Janssen on Immunotherapies Development
DJ
01/26Evotec Starts Oncology-development Collaboration With Johnson & Johnson Unit
MT
01/26Roche Develops New COVID-19 PCR Test for Omicron Subvariant XBB.1.5
MT
01/26Roche launches new test to detect fast spreading Omicron sub-variant
RE
01/26Roche Launches COVID-19 PCR Test to Detect the Fast Spreading XBB.1.5 Omicron Sub-Varia..
CI
01/25Merck & Co.'s Keytruda Combo Prolongs Survival in Late-stage Biliary Tract Cancer Study
MT
01/25Morgan Stanley Adjusts Price Target on Johnson & Johnson to $180 From $176, Maintains E..
MT
01/25Roche, Sysnav to Develop Outcome Measurements for Movement Impairment Ailments
MT
01/25NOVO NORDISK : Buy rating from JP Morgan
MD
01/25Atlantic Equities Adjusts Johnson & Johnson's Price Target to $168 From $160, Keeps Neu..
MT
01/25Novo Nordisk Signs New License Agreement with Howwe Technologies
MT
01/25Merck to Cease Phase 3 Trial for Treatment of Prostate Cancer Due to Failure in Meeting..
MT
01/25Merck Reports Keytruda Phase 3 Success, Failure
DJ
01/25Merck Announces KEYNOTE-991 Trial Evaluating KEYTRUDA« (pembrolizumab) Plus Enzalutamid..
CI
01/25Merck’s KEYTRUDA« (pembrolizumab) Plus Chemotherapy Significantly Improved Overall..
CI
01/25NOVO NORDISK : Receives a Buy rating from Goldman Sachs
MD
01/25ROCHE HOLDINGS AG : Barclays reaffirms its Buy rating
MD
01/25NOVO NORDISK : Barclays keeps its Buy rating
MD
01/25Sysnav Healthcare Announces A Multi-Year Collaboration with Roche Based on Sysnav's Pro..
CI
01/25RLS Global Chairman to Depart in February; Successor Nominated
MT
01/24Sector Update: Health Care Stocks Still Sagging Near Close
MT
01/24Merck & Company Keeps Quarterly Dividend at $0.73 a Share; Payable April 10 to Holders ..
MT
01/24Surprise Manufacturing Gain Leaves Equities Mixed
MT
01/24Sector Update: Health Care Stocks Retreating on Tuesday
MT
01/24Sector Update: Health Care
MT
01/24Merck Announces Dividend for the Second-Quarter of 2023 , Payable on April 10, 2023
CI
01/24Technology Heavyweights Earnings Kick-Start, Unexpected Improvement in Manufacturing In..
MT
01/24Johnson & Johnson on Track for Longest Losing Streak Since August 1981 -- Data Talk
DJ
01/24Johnson &Johnson CFO on Earnings Forecast, Costs, and Consumer Spinoff
MT
01/24Global markets live: GE, J&J, Verizon, Lockheed Martin, Halliburton...
MS
01/24Sector Update: Health Care Stocks Flat to Lower Pre-Bell Tuesday
MT
01/24Prospect of Further Federal Reserve Interest Rate Increases Pressuring Exchange-Traded ..
MT
01/24Johnson & Johnson Fourth-Quarter Revenue Falls on Lower COVID-19 Vaccine Sales; Guides ..
MT
01/24Transcript : Johnson & Johnson, Q4 2022 Earnings Call, Jan 24, 2023
CI
01/24FTSE 100 down as UK PMIs raise recession fears
AN
01/24Eli Lilly to Allocate Another $450 Million Toward Manufacturing Capacity Expansion at N..
MT
01/24Johnson & Johnson Q4 Adjusted Profit Rises; Sales Drop; Full-Year 2023 Guidance Release..
MT
01/24Eli Lilly Plans $450 Million Investment To Expand US Manufacturing Site
MT
01/24Eli Lilly and Company Plans to Invest Additional $450 Million At Manufacturing Site in ..
CI
01/24Earnings Flash (JNJ) JOHNSON & JOHNSON Reports Q4 Revenue $23.71B, vs. Street Est of $2..
MT
01/24Earnings Flash (JNJ) JOHNSON & JOHNSON Reports Q4 EPS $2.35, vs. Street Est of $2.24
MT
01/24Johnson & Johnson Reports Earnings Results for the Fourth Quarter Ended January 01, 202..
CI
01/24Johnson & Johnson Reports Earnings Results for the Full Year Ended January 01, 2023
CI
01/23Global markets live: Abbott, Goldman Sachs, Alphabet, Eli Lilly, Pay..
MS
01/23SVB Securities Adjusts Merck & Co.'s Price Target to $120 From $112, Keeps Outperform R..
MT
01/23Stocks Edge Down Pre-Bell Over Lack of Catalysts; Asia Strong, Europe Wobbles
MT
01/23ROCHE HOLDINGS AG : Goldman Sachs remains its Buy rating
MD
01/22Eli Lilly Seeks US FDA Nod for Expanded Use of Diabetes Pill Jardiance in Chronic Kidne..
MT
01/20S&P 500 Posts 0.7% Weekly Drop as Q4 Reports Add to Recession Fears; Industrials Lead D..
MT
01/20Eli Lilly & Co Announces FDA Decision Not to Grant Accelerated Approval to Donanemab fo..
CI
01/20Johnson & Johnson's 2023 Outlook to be in Focus, With Fourth-Quarter Results Seen Toppi..
MT
01/20Johnson & Johnson Q4 Results Likely to be In-Line With Outlook, BofA Says
MT
01/20Eli Lilly's NDA for Jardiance to Treat Chronic Kidney Disease Accepted by FDA
MT
01/20Sector Update: Health Care Stocks Mixed Premarket Friday
MT
01/20US FDA Accepts Supplemental New Drug Application for Jardiance« for Adults with Chronic..
CI
01/20Sector Update: Health Care
MT
01/20NOVO NORDISK : UBS reaffirms its Sell rating
MD
01/20SVB Securities Adjusts Price Target on Johnson & Johnson to $186 From $194, Maintains O..
MT
01/20Eli Lilly Alzheimer's drug setback extends rival Biogen's lead - analysts
RE
01/20ROCHE HOLDINGS AG : UBS remains Neutral
MD
01/20Eli Lilly Says FDA Rejected Accelerated Approval for Alzheimer's Drug Due to Insufficie..
MT
01/19Eli Lilly Fails to Clinch Accelerated Approval for Alzheimer's Drug in US
MT
01/19Eli Lilly and Company Announces U.S. Food and Drug Administration Issues Complete Respo..
CI
01/19Evaxion Biotech Says Cancer Immunotherapy Candidate EVX-01, With Keytruda, Gets US FDA ..
MT
01/19ROCHE HOLDINGS AG : Buy rating from Goldman Sachs
MD
01/19ROCHE HOLDINGS AG : JP Morgan remains a Sell rating
MD
01/19ROCHE HOLDINGS AG : Downgraded to Sell by Deutsche Bank
MD
01/19Roche's Liver Cancer Combo Extends Recurrence-free Survival In Late-stage Study
MT
01/19Roche Announces the Phase III IMbrave050 Study Met Its Primary Endpoint of Recurrence-F..
CI
01/18Switzerland's Roche Signs Partnership in Hong Kong to Boost Life Science Innovation
MT
Upcoming event on ABBVIE INC.